Stock listing
Alzecure Pharma Ab
Selected listing: ALZCUR · OMXSTO · SEK · SE
Alzecure Pharma Ab (Stockholm:ALZCUR), Health Technology. Latest release Sep 18, 2026: AlzeCure Pharma Publishes Updated Company Presentation Following…
- Ticker
- Stockholm:ALZCUR
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- Stockholm
- Currency
- SEK
About Alzecure Pharma Ab
Alzecure Pharma AB is a public company listed on the Swedish market under the ticker ALZCUR. Alzecure focuses on developing innovative treatments for neurological diseases, aiming to address significant unmet medical needs in this area.
Latest news from Alzecure Pharma Ab
AlzeCure Pharma Publishes Updated Company Presentation Following the Eli Lilly and QuantumCell Agreements
September 18, 2026
AlzeCure Pharma to Present at Aktiedagen in Stockholm on September 15
September 8, 2026
AlzeCure Receives a USD 10 Million Upfront Payment and Completes Initial Transaction with Lilly
August 18, 2026
AlzeCure Receives a Total Upfront Payment of USD 12 million and Completes the Initial Transaction with QuantumCell
August 12, 2026
AlzeCure Pharma Resolves on a Directed Share Issue to QuantumCell
August 3, 2026